Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1741 AL 1755

Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases

Ries HM, Nussbaum-Krammer C.

Essays Biochem. 2016 Oct 15;60(2):181-190. doi: 10.1042/EBC20160008.

Deep brain stimulation could cause delayed and recurrent cerebral ischemia: a case report

Wang Y, Liu H, Li P, Wang W.

Acta Neurochir (Wien). 2016 Dec;158(12):2369-2372. doi: 10.1007/s00701-016-2983-1. Epub 2016 Oct 15.

Genetic association of NOS1 exon18, NOS1 exon29, ABCB1 1236C/T, and ABCB1 3435C/T polymorphisms with the risk of Parkinson's disease: A meta-analysis

Huang H, Peng C, Liu Y, Liu X, Chen Q, Huang Z.

Medicine (Baltimore). 2016 Oct;95(40):e4982. doi: 10.1097/MD.0000000000004982.

In Vivo Morphology of the Optic Nerve and Retina in Patients With Parkinson's Disease

Pilat A, McLean RJ, Proudlock FA, Maconachie GD, Sheth V, Rajabally YA, Gottlob I.

Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4420-4427. doi: 10.1167/iovs.16-20020.

Constipation: an emerging risk factor for Parkinson's disease?

Stirpe P, Hoffman M, Badiali D, Colosimo C.

Eur J Neurol. 2016 Nov;23(11):1606-1613. doi: 10.1111/ene.13082. Epub 2016 Jul 22.

The roles of non-coding RNAs in Parkinson's disease

Majidinia M, Mihanfar A, Rahbarghazi R, Nourazarian A, Bagca B, Avci ÇB.

Mol Biol Rep. 2016 Nov;43(11):1193-1204. doi: 10.1007/s11033-016-4054-3. Epub 2016 Aug 5.

The Histamine H3 Receptor: Structure, Pharmacology, and Function

Nieto-Alamilla G, Márquez-Gómez R, García-Gálvez AM, Morales-Figueroa GE, Arias-Montaño JA.

Mol Pharmacol. 2016 Nov;90(5):649-673. doi: 10.1124/mol.116.104752. Epub 2016 Aug 25.

Nonmotor symptoms in Parkinson's disease: are we still waiting for the honeymoon?

Colosimo C, Bhidayasiri R.

Eur J Neurol. 2016 Nov;23(11):1595-1596. doi: 10.1111/ene.13123. Epub 2016 Sep 9.

l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?

Del-Bel E, Bortolanza M, Dos-Santos-Pereira M, Bariotto K, Raisman-Vozari R.

Synapse. 2016 Dec;70(12):479-500. doi: 10.1002/syn.21941. Epub 2016 Sep 27.

Could cancer drugs be repurposed for use in Parkinson's and Alzheimer's?

Moussa C.

Expert Rev Neurother. 2016 Dec;16(12):1335-1336. doi: 10.1080/14737175.2016.1248411. Epub 2016 Oct 27.

LRRK2 and the new era of Parkinson's disease research

The Lancet Neurology.

Lancet Neurol. 2016 Nov;15(12):1195. doi: 10.1016/S1474-4422(16)30077-1. Epub 2016 Oct 11.

The epidemiology of Parkinson's disease: risk factors and prevention

Ascherio A, Schwarzschild MA.

Lancet Neurol. 2016 Nov;15(12):1257-1272. doi: 10.1016/S1474-4422(16)30230-7. Epub 2016 Oct 11.

Shining light on the head: Photobiomodulation for brain disorders

Hamblin MR.

BBA Clin. 2016 Oct 1;6:113-124. doi: 10.1016/j.bbacli.2016.09.002. eCollection 2016 Dec.

Treatment of REM Sleep Behavior Disorder

Jung Y, St Louis EK.

Curr Treat Options Neurol. 2016 Nov;18(11):50. doi: 10.1007/s11940-016-0433-2.

Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS)

Cauley JA, Cawthon PM, Peters KE, Cummings SR, Ensrud KE, Bauer DC, Taylor BC, Shikany JM, Hoffman AR, Lane NE, Kado DM, Stefanick ML, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Study Research Group.

J Bone Miner Res. 2016 Oct;31(10):1810-1819. doi: 10.1002/jbmr.2836. Epub 2016 Apr 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias